Gene · 9966
Papers2,280
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,280
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Innovative pipeline therapeutics in inflammatory bowel disease: Anti-tumor necrosis factor-like ligand 1A and bispecific antibodies. | Curr Opin Pharmacol | 2026 | 41389455 | PubTator, text mining | PubMed |
| Comments on the Role of TL1A/DR3 Signaling and Th9 Cells in Crohn's Disease. | Gastroenterology | 2026 | 41317879 | PubTator, text mining | PubMed |
| Leaf it to science: Uncovering plant immune systems through technological advances. | Plant Physiol | 2026 | 41289031 | PubTator, text mining | PubMed |
| Brighter days ahead: the shifting landscape of IBD therapy. | Curr Opin Gastroenterol | 2026 | 41086285 | PubTator, text mining | PubMed |
| From Large to Small Cytokine Receptor Antagonists. | SLAS Discov | 2026 | 41052545 | PubTator, text mining | PubMed |
| Exploring the Potential of TL1A Inhibition in the Treatment of Inflammatory Bowel Disease Patients. | Gastroenterol Hepatol (N Y) | 2025 | 41624383 | PubTator, text mining | PubMed |
| Expression of concern: "TL1A promotes metastasis and EMT process of colorectal cancer" [Heliyon 10 (2024) e24392]. | Heliyon | 2025 | 41497879 | PubTator, text mining | PubMed |
| Dynamic neutrophil-keratinocyte communication network centered on IL-36/TNFSF15 responses characterizes inflammatory responses in generalized pustular psoriasis. | Nat Commun | 2025 | 41436466 | PubTator, text mining | PubMed |
| TL1A blockade in inflammatory bowel diseases: Clinical trials to watch. | Med | 2025 | 41389712 | PubTator, text mining | PubMed |
| Loss of ADAM15 prevents necroptosis induction by partial RIPK1 degradation due to enhanced TNF-R1 surface expression and basal caspase-8 activation. | Cell Commun Signal | 2025 | 41340056 | PubTator, text mining | PubMed |
| Age-Related Survival Disparities in Advanced Renal Carcinoma in the Immune Checkpoint Inhibitor Era using the SEER Database and Meta-analysis. | Sci Rep | 2025 | 41339655 | PubTator, text mining | PubMed |
| METTL14 Regulates the Expression of Genes Related to Interferon, Interleukin and MHC Class I in Nasopharyngeal Carcinoma Cells. | Cancer Med | 2025 | 41316520 | PubTator, text mining | PubMed |
| Emerging Role and Function of Th9 Cells in Allergic Inflammation. | J Inflamm Res | 2025 | 41312549 | PubTator, text mining | PubMed |
| A robust EMT-related prognostic model for ccRCC integrating single-cell and bulk transcriptome data. | Discov Oncol | 2025 | 41212297 | PubTator, text mining | PubMed |
| Causal relationship between chronic inflammatory diseases and uveal melanoma: A bidirectional Mendelian randomization study. | Indian J Ophthalmol | 2025 | 41148015 | PubTator, text mining | PubMed |
| First genome-wide association study reveals immune-mediated aetiopathology in idiopathic achalasia. | Gut | 2025 | 41136183 | PubTator, text mining | PubMed |
Serum levels of tumor necrosis factor-like cytokine 1A and its receptors, death receptor 3 and decoy receptor 3, in patients with spondyloarthropathies: preliminary results from a cross-sectional study. | Reumatologia | 2025 | 41064385 | PubTator, text mining | PubMed |
| Ophthalmic drug discovery and development using artificial intelligence and digital health technologies. | NPJ Digit Med | 2025 | 40998989 | PubTator, text mining | PubMed |
| Immune subtyping of lymph node metastasis-negative colorectal cancer reveals biomarkers for prognosis and immunotherapy response. | PLoS One | 2025 | 40991561 | PubTator, text mining | PubMed |
| Keeping the network alive: The importance of professional social networks for long-term research career development. | J Clin Transl Sci | 2025 | 40979106 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9966/papers?page=4